Cow’s milk protein allergy in infants
Cow’s milk protein allergy (CMPA) is an immune response to proteins in cow’s milk. It can affect different body systems and cause symptoms that vary in their timing, severity and presentation. Some reactions occur quickly, while others develop over hours or days (NICE, 2011; Vandenplas et al., 2024).
Cow’s milk allergy can be difficult to recognise because many of the symptoms associated with it are also common in babies who do not have an allergy. Symptoms such as reflux, colic, unsettled behaviour, changes in stools and eczema are not, on their own, sufficient to diagnose CMPA.
Overdiagnosis is a recognised problem. An unnecessary diagnosis may result in restrictive diets, inappropriate formula changes, nutritional difficulties, additional expense and anxiety for families. A structured assessment, appropriate elimination trial where indicated, and planned reintroduction are important parts of confirming the diagnosis (Vandenplas et al., 2024).
What is cow’s milk protein allergy?
Cow’s milk protein allergy occurs when the immune system reacts to proteins found in cow’s milk. The reaction may involve the skin, digestive system, respiratory system or more than one area of the body.
Cow’s milk contains several proteins, including casein and whey proteins. In CMPA, the immune system identifies one or more of these proteins as a threat and produces an allergic response.
This is different from lactose intolerance, which involves difficulty digesting lactose, the sugar naturally present in milk.
Cow’s milk allergy can occur in babies who are breastfed, formula-fed or combination-fed, although confirmed CMPA in exclusively breastfed infants is uncommon (Vandenplas et al., 2024).
Types of cow’s milk allergy
Cow’s milk allergy is commonly classified according to the immune mechanism involved.
Type | How it works | Typical timing |
IgE-mediated | The immune system produces immunoglobulin E (IgE) antibodies against cow’s milk proteins. These antibodies trigger the release of histamine and other inflammatory mediators from cells involved in allergic reactions. | Usually within minutes and generally within around two hours of exposure. |
Non-IgE-mediated | The immune response involves mechanisms other than IgE antibodies. The reaction may involve inflammation affecting the skin or digestive system. | Symptoms may be delayed, occurring hours or sometimes days after exposure. |
Mixed | Both IgE-mediated and non-IgE-mediated mechanisms may be involved. | Symptoms may be immediate and/or delayed, depending on the mechanisms involved. |
These classifications help guide assessment and management, although symptoms and their timing do not always fit neatly into one category (NICE, 2011; Vandenplas et al., 2024).
IgE-mediated allergy
IgE-mediated allergy involves the production of specific IgE antibodies against a food protein.
When the protein is encountered again, it can bind to these antibodies on mast cells and basophils, triggering the release of histamine and other chemical mediators. These substances can cause symptoms such as hives, swelling, vomiting, coughing, wheezing and, in severe cases, anaphylaxis.
Reactions generally occur rapidly following exposure. Skin-prick testing or specific IgE blood tests may be useful where the clinical history suggests an IgE-mediated allergy. However, a positive test indicates sensitisation and does not necessarily mean that eating the food will cause an allergic reaction. Test results must be interpreted alongside the history (NICE, 2011).
Non-IgE-mediated allergy
Non-IgE-mediated CMPA involves immune responses that do not follow the immediate IgE pathway. Symptoms may be delayed and can involve the gastrointestinal tract, skin and general wellbeing.
Because symptoms may develop gradually, it can be difficult to identify a relationship between milk exposure and symptoms. Some symptoms may also fluctuate naturally, making it important not to assume that every change is caused by cow’s milk protein.
There is no skin-prick test or specific IgE blood test that can diagnose non-IgE-mediated CMPA. Diagnosis generally relies on the clinical history and, where appropriate, a planned elimination and reintroduction of cow’s milk protein (NICE, 2011; Vandenplas et al., 2024).
Food Protein-Induced Enterocolitis Syndrome (FPIES)
Food Protein-Induced Enterocolitis Syndrome (FPIES) is a type of non-IgE-mediated food allergy that can cause significant delayed gastrointestinal reactions.
In acute FPIES, repeated vomiting typically occurs around one to four hours after the trigger food has been consumed. A baby may become pale, lethargic or floppy. Diarrhoea may occur later. Unlike typical IgE-mediated reactions, hives, swelling and breathing symptoms are usually absent.
Cow’s milk and soya are recognised triggers, although FPIES can occur in response to other foods.
FPIES requires appropriate clinical assessment. There is no specific skin-prick or specific IgE blood test that diagnoses FPIES. Food challenges and reintroduction should be planned with the specialist team, as significant reactions can occur (Allergy UK, 2021; Allergy UK, 2026).
Symptoms of cow’s milk allergy
Symptoms of CMPA can affect different body systems and may occur individually or in combination.
Body system | Possible symptoms |
Skin | Eczema, itchy skin, redness, hives or swelling |
Gastrointestinal | Vomiting, diarrhoea, constipation, reflux-like symptoms, abdominal discomfort, blood or mucus in stools |
Respiratory | Coughing, wheezing, runny nose, nasal congestion or breathing difficulty |
Feeding | Feeding discomfort, refusal, distress during feeds or changes in feeding behaviour |
General | Poor weight gain, faltering growth, lethargy or feeling generally unwell |
Symptoms such as colic, reflux, eczema, unsettled behaviour and changes in stools are common during infancy and are not specific to CMPA. Their severity, frequency, timing, combination and relationship to milk exposure need to be considered alongside the baby's feeding history, growth and general health (NICE, 2011; Vandenplas et al., 2024).
Changes in stool colour, consistency or frequency do not automatically indicate an allergy. Stool patterns vary considerably between babies, including those who are breastfed. Breastfed baby poop (Pearson-Glaze, 2025) explains normal variation in breastfed babies’ stools.
Colic, reflux and other feeding symptoms
Colic is a pattern of prolonged crying or distress in an otherwise healthy baby. It is not a diagnosis of a single underlying cause. Babies may cry for a range of reasons, and crying, reflux-like symptoms and feeding difficulties can overlap.
Cow’s milk allergy is sometimes considered when symptoms are persistent or accompanied by other features suggestive of allergy. However, colic or reflux alone does not establish CMPA.
Managing the baby with colicky symptoms (Banks, 2017) discusses assessment and support for babies with colicky symptoms.
Reflux is also common in infancy and may occur without an underlying allergy. Feeding mechanics, milk flow, swallowed air, feeding volumes and normal infant development can all be relevant when considering reflux-like symptoms. Infant Reflux: Feeding, Self-Help and when to Seek Support discusses reflux, feeding factors, assessment and when further support may be needed.
Feeding aversion or refusal may also develop for a number of reasons and should not automatically be attributed to allergy.
Bottle aversion and Breastfeeding aversion explore both breast and bottle feeding refusal, and the importance of understanding a baby's feeding experience.
When feeding difficulties persist, it may be helpful to consider the wider feeding picture rather than focusing on a single symptom or diagnosis. When feeding doesn't feel right discusses feeding difficulties and the importance of considering different contributing factors.
Family history
A family history of allergic conditions may be relevant when assessing a baby with possible CMPA.
Conditions such as eczema, asthma, hay fever, allergic rhinitis and food allergy may occur within families. A family history can help inform clinical assessment, but it does not mean that a baby will necessarily develop an allergy.
The presence or absence of family history does not confirm or exclude CMPA (NHS, 2020; NICE, 2011).
Diagnosis and allergy testing
Diagnosis begins with an allergy-focused clinical history and assessment. The history should consider the type of symptoms, their severity, timing, frequency, relationship to exposure, feeding history, growth and any previous reactions.
Questions may include:
What milk or food was consumed?
How much was consumed?
Was the exposure directly through the baby's diet or potentially through breastmilk?
How quickly did symptoms develop?
How long did symptoms last?
What symptoms occurred and how severe were they?
Has the reaction happened more than once?
Were there any changes to feeding, maternal diet or formula?
Was the baby unwell for another reason at the time?
What is the baby's growth and general health?
Skin-prick testing or specific IgE blood testing may be appropriate where the history suggests an IgE-mediated allergy. These tests should be undertaken and interpreted by healthcare professionals with appropriate competencies.
A positive test does not necessarily mean that a baby has a clinical food allergy. It may indicate sensitisation without symptoms when the food is eaten. The results therefore need to be considered alongside the history.
Skin-prick testing and specific IgE blood testing are not diagnostic tests for non-IgE-mediated CMPA. Where non-IgE-mediated allergy is suspected, a planned elimination and reintroduction may be used to help confirm the diagnosis (NICE, 2011; Vandenplas et al., 2024).
Keeping a feeding and symptom diary
A diary may help families record what is happening and provide useful information during an assessment. It is intended to record observations and patterns rather than act as a checklist for diagnosing allergy.
A diary may include:
What was eaten or consumed, including amounts and timings.
Whether the baby was breastfed, bottle-fed or combination-fed.
Symptoms and when they started.
How long symptoms lasted.
Changes in stools.
Skin changes, including photographs where appropriate.
Feeding behaviour and changes in comfort.
Sleep and periods of distress.
Changes to formula, maternal diet or feeding routines.
Other factors that may be relevant, such as illness or medicines.
A diary does not diagnose CMPA. It may, however, help clarify the history and avoid unnecessary dietary changes based on isolated symptoms.
Oral food challenges
An oral food challenge is a clinical test used to help confirm or rule out a food allergy. During the challenge, small, measured amounts of the suspected food are given, usually in gradually increasing amounts, while the person is closely monitored for signs of an allergic reaction.
This is not the same as introducing solids during weaning.
Oral food challenges are carried out under medical supervision in a safe setting, such as a hospital or allergy clinic, where staff have the knowledge and equipment to recognise and manage allergic reactions. They may be recommended where the diagnosis is uncertain, where allergy testing and the history need clarification, or to assess whether an allergy has been outgrown (Allergy UK, 2022; NICE, 2011).
The type of challenge and the level of supervision required depend on the suspected allergy, previous reactions and clinical assessment. Families should not undertake an oral food challenge independently.
Elimination and reintroduction
When non-IgE-mediated CMPA is suspected, a time-limited elimination diet followed by reintroduction is an important part of confirming the diagnosis.
The ESPGHAN position paper (2024) recommends a diagnostic elimination period of around two to four weeks for suspected non-IgE-mediated CMPA. NICE recommends an elimination trial, normally between two and six weeks, followed by reintroduction. Appropriate dietary and clinical support is important during this process (NICE, 2011; Vandenplas et al., 2024).
Improvement during an elimination period does not, on its own, confirm CMPA. Symptoms may improve naturally, fluctuate or respond to changes unrelated to cow’s milk protein. Reintroduction is therefore an important part of determining whether cow’s milk protein was responsible.
Reintroduction must follow medical advice and the plan agreed with the healthcare professional. The approach will depend on the type of suspected allergy and the baby's history.
An oral food challenge may be required where there is a suspected IgE-mediated allergy, a history of immediate reactions, severe reactions or other clinical concerns. The setting and level of supervision should be determined by the allergy team or appropriately qualified healthcare professional (Allergy UK, 2022; NICE, 2011).
A milk ladder may sometimes be advised as part of a later management plan for selected babies and children with confirmed CMPA. It is not a substitute for diagnostic assessment and should only be used according to professional advice.
Breastfeeding and cow’s milk allergy
Breastfeeding can usually continue when CMPA is suspected or confirmed. Cow’s milk allergy in exclusively breastfed infants is uncommon, and maternal dairy exclusion is not routinely necessary simply because a baby has symptoms (Vandenplas et al., 2024).
Cow’s milk proteins can pass into breastmilk in very small amounts, but this does not mean that every breastfed baby experiencing reflux, colic, eczema or unsettled behaviour has CMPA.
Where CMPA is suspected in an exclusively breastfed baby, a time-limited maternal dairy exclusion may occasionally be considered following clinical assessment. This should have a clear rationale, duration and plan for reintroduction rather than becoming a prolonged restriction without confirmation.
If a maternal dairy-free diet is advised, nutritional adequacy needs to be considered. Calcium and vitamin D supplementation may be required, and iodine or vitamin B12 may also need consideration depending on the mother's diet. Dietetic advice can be particularly useful where several foods are being excluded (NICE, 2011; Vandenplas et al., 2024).
Breastfeeding support should continue throughout any diagnostic process. If expressing is needed to maintain milk supply or support feeding during changes to a baby's diet, appropriate support with expressing and milk removal may be helpful.
Formula feeding and cow’s milk allergy
Where formula is required for a baby with suspected or confirmed CMPA, formula choice depends on the clinical presentation, severity and whether allergy has been appropriately assessed.
Formula should be selected according to clinical advice rather than simply choosing a product based on its marketing or brand.
Formula type | Role and suitability for CMPA |
Extensively hydrolysed formula (eHF) | Generally the first choice for many formula-fed infants with suspected or confirmed CMPA. The proteins have been broken down extensively to reduce their allergenic potential. |
Amino acid formula (AAF) | May be indicated for severe presentations, significant nutritional concerns or where an extensively hydrolysed formula is not tolerated or symptoms persist despite an appropriate trial. |
Hydrolysed rice-protein formula (HRF) | A specialist formula option that may be considered where clinically appropriate. It is not the same as an ordinary rice drink. |
Soya infant formula | May be considered in selected circumstances, generally from six months of age and under medical supervision. Soya allergy may coexist with CMPA. |
Partially hydrolysed or comfort formula | Contains cow’s milk proteins that have only been partially broken down. It is not hypoallergenic and is not suitable for treating CMPA. |
Lactose-free formula | Removing lactose does not remove cow’s milk proteins. Lactose-free cow’s milk formula is not suitable for CMPA. |
Extensively hydrolysed formula is generally the first choice for a diagnostic elimination diet in formula-fed infants. Amino acid formula is usually reserved for severe cases or where an extensively hydrolysed formula is not appropriate or has not been effective. Hydrolysed rice formulas may be considered as an alternative in appropriate circumstances, while soya infant formula is not generally the first choice and requires consideration of age and clinical suitability (NHS, 2023; Vandenplas et al., 2024).
Formula types that are NOT suitable for CMPA
The following products are not suitable substitutes for an appropriate hypoallergenic formula when a baby has CMPA:
Formula or milk | Why it is NOT suitable |
Standard cow’s milk-based infant formula | Contains cow’s milk proteins that may trigger an allergic reaction. |
Partially hydrolysed or comfort formula | The proteins are only partially broken down. It is not hypoallergenic and is not suitable for CMPA. |
Lactose-free cow’s milk formula | Lactose is a sugar. Removing lactose does not remove the cow’s milk proteins responsible for CMPA. |
Goat’s milk formula | Goat’s milk proteins are sufficiently similar to cow’s milk proteins that cross-reactivity can occur. |
Sheep’s milk | Sheep’s milk proteins are similar to cow’s milk proteins and are not a suitable alternative for CMPA. |
A2 cow’s milk formula | A2 milk still contains cow’s milk proteins and is not suitable for CMPA. |
Ordinary plant-based drinks | These are not nutritionally suitable substitutes for infant formula during the first year. |
The choice of an appropriate formula should be discussed with the healthcare professional managing the suspected or confirmed allergy.
Combination feeding and maternal dairy exclusion
For babies receiving both breastmilk and formula, the feeding history is important when considering possible CMPA.
Where symptoms are nonspecific and allergy is not strongly suspected, the feeding situation should be assessed rather than automatically recommending maternal dairy exclusion. Breastfeeding parents should not routinely be asked to remove dairy from their diet solely because a baby is unsettled, has reflux-like symptoms or experiences colic.
If CMPA is suspected, changing to a partially hydrolysed formula alone is not an appropriate diagnostic or treatment strategy. A planned elimination may involve an appropriate hypoallergenic formula for supplementary feeds and, where breastmilk exposure is thought to contribute to symptoms, a time-limited maternal dairy exclusion.
The plan should include reassessment and reintroduction to help confirm or rule out the diagnosis, with nutritional support where needed (NICE, 2011; Vandenplas et al., 2024).
Lactose intolerance is not milk allergy
Lactose is a sugar naturally present in human milk, cow’s milk, goat’s milk and sheep’s milk.
Lactose intolerance occurs when the body cannot digest lactose adequately because of reduced lactase enzyme activity. It may cause symptoms such as abdominal discomfort, wind, bloating and diarrhoea.
Food allergy involves an immune reaction to a food protein, whereas lactose intolerance involves difficulty digesting a sugar. The two conditions are different and require different management.
Lactose-free products still contain milk proteins unless specifically formulated otherwise, so lactose-free formula is not appropriate treatment for cow’s milk allergy.
Lactose intolerance is uncommon in young babies. Temporary lactose intolerance can sometimes occur following gastrointestinal illness or damage to the intestinal lining. In some cases of severe CMPA affecting the gut, inflammation or intestinal damage may temporarily affect the ability to absorb nutrients, including lactose, and contribute to diarrhoea or malabsorption. This does not occur in every baby with CMPA (NHS, 2023; Vandenplas et al., 2024).
Maternal dairy exclusion does not reduce the lactose naturally present in breastmilk because lactose is produced in the breast rather than transferred directly from the mother's diet.
Growth, nutrition and malabsorption
Some babies with CMPA may experience persistent diarrhoea, vomiting, feeding difficulties or inflammation affecting the gastrointestinal tract. In more severe cases, this may contribute to nutritional difficulties, malabsorption, nutrient deficiencies, anaemia or faltering growth.
These problems are not present in every baby with CMPA. Growth and nutritional status are important parts of assessment, particularly where symptoms are persistent, severe or associated with reduced intake.
If a baby is losing weight, faltering in growth or showing signs of nutritional compromise, they need appropriate clinical assessment rather than simply attributing the symptoms to allergy.
There is currently no high-energy formula that is both dairy-free and suitable for CMPA available as a straightforward routine alternative. Where a baby requires additional energy or nutritional support, this needs individual assessment and specialist advice rather than an independent formula change.
The gut microbiome, probiotics and prebiotics
The gut microbiome is the community of microorganisms living within the digestive tract. These microorganisms interact with digestion, immune function and the development of the intestinal environment.
Prebiotics are substances that can be used by gut microorganisms and may selectively support the growth or activity of particular bacteria. Probiotics are live microorganisms that may provide health benefits when specific strains are used in appropriate circumstances. Synbiotics combine probiotics and prebiotics.
Research is exploring how the gut microbiome relates to allergy development, immune responses and the development of tolerance to cow’s milk protein. However, evidence does not currently support routinely using probiotics, prebiotics or synbiotics as treatment for CMPA. The 2024 ESPGHAN position paper found insufficient evidence to recommend adding these products to an elimination diet to improve CMPA outcomes (Vandenplas et al., 2024).
Products marketed as probiotics, prebiotics or synbiotics are not interchangeable. Evidence relating to one particular strain or combination cannot automatically be applied to every product. Families should discuss their use with an appropriate healthcare professional, particularly where a baby is premature or medically vulnerable.
Introducing complementary foods
Complementary foods are generally introduced from around six months of age when a baby is developmentally ready. Breastmilk or infant formula remains the main drink during the first year (NHS, 2026).
The presence of CMPA does not mean that all other allergenic foods should be unnecessarily delayed. Foods such as egg, peanut, fish, wheat and soya can be introduced from around six months in age-appropriate forms, taking account of the baby's history and any individual advice.
Allergenic foods should be introduced one at a time and in small amounts so that any reaction can be recognised. Once a food is tolerated, it should continue to be offered regularly as part of the baby's usual diet (NHS, 2023; NHS, 2026).
Babies with an existing food allergy, severe eczema or other significant allergy concerns may need individual advice before introducing particular foods.
Plant-based drinks should not replace breastmilk or infant formula as the main drink during the first year. Ordinary rice drinks should not be given to children under five because of concerns about inorganic arsenic exposure (NHS, 2023).
Recognising a severe allergic reaction
Anaphylaxis is a severe, potentially life-threatening allergic reaction. Symptoms may include:
Sudden swelling of the tongue or throat.
Difficulty breathing.
Wheezing or severe breathing symptoms.
Collapse.
Marked dizziness.
A baby becoming floppy or unresponsive.
If anaphylaxis is suspected, use a prescribed adrenaline auto-injector immediately, call 999 and follow the baby's emergency allergy plan. Antihistamines must not delay adrenaline in anaphylaxis (NHS, 2023; MHRA, 2023).
When to seek help
Seek prompt medical assessment if a baby has:
Blood in their stools.
Repeated vomiting.
Persistent diarrhoea.
Signs of dehydration or reduced wet nappies.
Feeding difficulties or refusal of feeds.
Poor weight gain, faltering growth or weight loss.
Persistent or worsening symptoms.
Unusual lethargy or a baby who appears unwell.
Breathing difficulty, tongue or throat swelling, collapse or a baby becoming floppy or unresponsive are emergencies requiring 999.
Collaborative feeding and allergy support
Assessment and management may involve the GP, health visitor, paediatrician, allergy specialist, dietitian and infant feeding specialist, depending on the baby's presentation and needs.
Specialist assessment may be particularly important where there are immediate or severe reactions, faltering growth, multiple suspected allergies, significant feeding difficulties, persistent symptoms despite an elimination diet, or uncertainty about diagnosis or formula choice (NICE, 2011).
Families should not be left managing restrictive diets, feeding difficulties or potentially severe allergic reactions without appropriate support.
The aim is to identify whether cow’s milk protein allergy is genuinely present, support the baby's nutritional needs, avoid unnecessary restriction and ensure that feeding and breastfeeding support continue throughout the assessment and management process.
References
Allergy UK (2021) FPIES (Food Protein Induced Enterocolitis Syndrome). Published 15 October 2021. Available at: https://www.allergyuk.org/resources/fpies-food-protein-induced-enterocolitis-syndrome/
Allergy UK (2022) Oral Food Challenge. Published 23 February 2022. Available at: https://www.allergyuk.org/resources/oral-food-challenge/
National Charity
Allergy UK (2022) FPIES (Food Protein Induced Enterocolitis Syndrome). Version 3, reviewed March 2022. Available at: https://www.allergyuk.org/resources/fpies-food-protein-induced-enterocolitis-syndrome/
Allergy UK (2026) Food Protein Induced Enterocolitis Syndrome (FPIES) – Information for GPs. Reviewed March 2026. Available at: https://www.allergyuk.org/resources/fpies-information-for-gps/
Allergy UK (2021) Food Allergy Testing and Diagnosing. Published 6 July 2021. Available at: https://www.allergyuk.org/resources/food-allergy-testing-and-diagnosing/
Banks, S. (2017) Managing the baby with colicky symptoms. Shel Banks. Published 20 December 2017. Available at: https://shelbanks.co.uk/managing-baby-colicky-symptoms
Medicines and Healthcare products Regulatory Agency (MHRA) (2023) Adrenaline auto-injectors (AAIs): new guidance and resources for safe use. Published 27 June 2023. Available at: https://www.gov.uk/drug-safety-update/adrenaline-auto-injectors-aais-new-guidance-and-resources-for-safe-use
National Institute for Health and Care Excellence (NICE) (2011) Food allergy in under 19s: assessment and diagnosis. Clinical guideline CG116. Published 23 February 2011. Available at: https://www.nice.org.uk/guidance/cg116
NHS (2020) Food allergies in babies and young children. Available at: https://www.nhs.uk/baby/weaning-and-feeding/food-allergies-in-babies-and-young-children/
NHS (2023) Types of formula milk. Available at: https://www.nhs.uk/baby/breastfeeding-and-bottle-feeding/bottle-feeding/types-of-formula/
NHS (2023) Drinks and cups for babies and young children. Available at: https://www.nhs.uk/baby/weaning-and-feeding/drinks-and-cups-for-babies-and-young-children/
NHS (2023) Breastfeeding and diet. Available at: https://www.nhs.uk/baby/breastfeeding-and-bottle-feeding/breastfeeding-and-lifestyle/diet/
NHS (2023) Breastfeeding vitamins. Available at: https://www.nhs.uk/best-start-in-life/baby/feeding-your-baby/breastfeeding/healthy-diet-when-breastfeeding/breastfeeding-vitamins/
NHS (2023) Introducing foods that could trigger an allergic reaction. Available at: https://www.nhs.uk/best-start-in-life/baby/weaning/safe-weaning/food-allergies/
NHS (2026) Your baby's first solid foods. Available at: https://www.nhs.uk/baby/weaning-and-feeding/babys-first-solid-foods/
Pearson-Glaze, P. (2025) Breastfed baby poop. Breastfeeding Support. Last revised 29 April 2025. Available at: https://breastfeeding.support/breastfed-baby-poop/
Vandenplas, Y., Broekaert, I., Domellöf, M., Indrio, F., Lapillonne, A., Pienar, C., Ribes-Koninckx, C., Shamir, R., Szajewska, H., Thapar, N., Thomassen, R.A., Verduci, E. and West, C. (2024) ‘An ESPGHAN Position Paper on the Diagnosis, Management, and Prevention of Cow’s Milk Allergy’, Journal of Pediatric Gastroenterology and Nutrition, 78(2), pp. 386–413. Available at: https://doi.org/10.1097/MPG.0000000000003897










Comments